lestaurtinib (CEP-701) - Teva, Kyowa Kirin
Venclexta (venetoclax) - Roche, AbbVie, Walter and Eliza Hall Institute
Xospata (gilteritinib) - Astellas
Turalio (pexidartinib) - Daiichi Sankyo
Vanflyta (quizartinib) - Daiichi Sankyo
azacitidine - Generic mfg.
Idhifa (enasidenib) - BMS, Servier
Rydapt (midostaurin) - Novartis
eragidomide (CC-90009) - BMS
Sutent (sunitinib) - Pfizer
crenolanib (ARO-002) - AROG
https://eventpilot.us/web/page.php?page=Session&project=ASH21&id=147160
 
Daniel W. Pierce1; Tsun-Wen Sheena Yao2; Emily Pace2; Hongbin Wang1; Pierre Flandin-Blety1; Alicia Benitez3; Carla Guarinos3; Matthew Hoffmann4; Soraya Carrancio5; Jinhong Fan2; Michael Pourdehnad6
 
Nov 5, 2021
 
Prev Next